Sabinsa Corporation has been granted its fourth patent on BioPerine®, a proprietary ingredient developed by the company which has been clinically shown to increase the bioavailibility of nutritional supplements, thus making them more effective. Additionally, the BioPerine® trademark has been officially accepted and recognized as a trademark in Europe.
This US patent, #6,054,585 was awarded April 25, 2000. The new patent awarded to Sabinsa is a process patent, explaining how the material is made and protecting the process Sabinsa developed, which results in obtaining pure piperine higher that other processes. Previous patents insured Sabinsa exclusive rights to offer piperine, the active compound in BioPerine® extracted from black pepper, regardless of its source, for use in nutritional compounds. Practically speaking, this means that no one can legally market or sell piperine for nutritional compounds except Sabinsa or its designated licensees. The only clinical studies done with piperine for nutritional purposes are with BioPerine®.
Additionally, Sabinsa has received Certificate of Registration 000286922 for the BioPerine® trademark, providing protection in the 15 member states of the European Union (EU).
Please contact Sabinsa Corporation for more information in New Jersey at 732-777-1111 or in Utah at 801-465-8400.
Sabinsa Corporation is an application-oriented manufacturing and marketing company which manufacturers and supplies Phytonutrients, Ayurvedic herbal extracts and specialty fine chemicals used for nutritional, pharmaceutical and food products. Sabinsa distinguishes itself by its extensive research support for its customers and products, and the scientific credentials of its key technical staff.